|
|
Getting the Most Out of Chatbots: The Promise and Perils of Artificial Intelligence
In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie tackles the remarkable (and seemingly controversial) advent of Artificial Intelligence (AI) and how to get the most out of using AI chatbot assistants (such as ChatGPT) for culling information from massive dataset resources. However, he also contrasts it with the possible pitfalls and disadvantages which may ensue from using this new technology. Dr. Durie delves deeper into the potential role of chatbots in addressing patient questions, the basics of using ChatGPT, as well as some common-sense warnings and “golden prompts” to better aid the user through the chatbot experience. While chatbots and AIs are here to stay, Dr. Durie strongly advises being cognizant of their limitations. He foresees that further improvements will still need to be made for AI tools to become optimal but is also optimistic that they will be beneficial to the myeloma community in the long run.
|
|
|
|
|
|
|
The International Myeloma Foundation (IMF) Honors 2023 Research Achievement Awardees, Dr. María-Victoria Mateos and Dr. Thomas Martin
The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award, which will be presented in an in-person awards ceremony on Thursday, June 8, at the 14th Annual International Myeloma Working Group (IMWG) Summit in Frankfurt, Germany. This year’s Robert A. Kyle Lifetime Achievement Awardee is Maria-Victoria Mateos, MD, PhD, Head of Myeloma and Clinical Trials Unit at the Haematology Department and Professor of Medicine at the University of Salamanca, Spain. This year’s Brian G.M. Durie Outstanding Achievement Awardee is Thomas G. Martin, III MD, Professor of Clinical Medicine; Associate Chief of Adult Hematology, Blood Marrow Transplantation and Cell Therapy (HBC); Co-Director of the Myeloma Program; and Clinical Research Director of Hematologic Malignancies at UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) Medical Center in San Francisco, California. The Kyle and Durie Achievement Awards are presented each year to outstanding and deserving individuals who have made significant contributions in the field of myeloma research.
|
|
|
|
|
|
|
The IMF Announces 2023 Brian D. Novis Research Grant Recipients
The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Brian D. Novis Research Grants, which were presented in an in-person awards ceremony on May 18, 2023, at the New England Aquarium in Boston. Senior Grant Recipient is Boaz Torah, PhD (Case Western Reserve University — Cleveland); and Junior Grant Recipients are Camille Edwards, MD (Boston University Medical Campus — Boston); and Julia Frede, PhD (Dana-Farber Cancer Institute — Boston). These prestigious research grants enable the brightest minds in myeloma research to conduct projects that fulfill the IMF’s mission of improving the quality of life of myeloma patients while working toward prevention and a cure. Learn about each recipient’s research proposal now.
|
|
|
|
|
|
|
IMF Patient, President & CEO Yelak Biru Featured in Innovation & Tech Today as a Guest Author
IMF Patient, President & CEO Yelak Biru co-authored “How Data for the Greater Good is Fostering Hope and Improving Outcomes” with Krishnan Venkata, Chief Client Officer at LatentView Analytics. The article highlights the importance of “data for the greater good.” It explains how the IMF is leveraging data, making “unifying data” its mission “to build a powerful education program for patients and their families who have received a myeloma diagnosis or relapse. In partnership with LatentView Analytics, IMF is shortening the “time to hope—the period from diagnosis or relapse to a patient’s realization that they can live with myeloma.” Read the full article to learn how the IMF leverages data to serve its mission.
|
|
|
|
|
|
|
Listen to “A Day in the Life” Podcast with Myeloma Care Partner Jill Schock
In this episode of the “A Day in the Life” podcast, Jill Schock shares her journey as a myeloma care partner, navigating the challenges of her husband's disease and finding strength in her role. Gain insights into adapting to life's unexpected twists, maintaining a strong support system, and embracing the hand you're dealt. Explore the triumphs, setbacks, and unwavering determination that define their fight against myeloma. Listen now for uplifting stories, expert advice, and a reminder that together, we can overcome any obstacle.
|
|
|
|
|
|
|
Watch Myeloma Experts Discuss CAR T Therapy
In this video, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie and IMF Chief Medical Officer Joseph Mikhael, MD, along with other myeloma experts, discuss the importance of CAR T Therapy as an innovative and groundbreaking approach to the treatment of multiple myeloma.
|
|
|
|
|
|
|
Now Accepting Applications: The 2024 Brian D. Novis Research Grants
The Brian D. Novis Research Grant was established in 1995 to honor IMF co-founder Brian D. Novis, who succumbed to multiple myeloma in July 1992. The grants are awarded to researchers working in the field of multiple myeloma and related disorders, including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The grants will support senior research projects with $80,000 each and junior research projects with $50,000 each. Deadline for submission of applications is August 28, 2023.
|
|
|
|
|
|
|
Watch This Episode of “Myeloma Made Simple” on Shared Decision Making
In this episode of “Myeloma Made Simple,” join IMF Chief Medical Officer Dr. Joseph Mikhael with special guests Michael Tuohy, who is a 23-year myeloma survivor, and IMF’s Vice President of Support Robin Tuohy. Hear about the power of shared decision making in myeloma treatment, where patients and healthcare providers collaborate to make informed choices. Learn how to navigate treatment options, understand risks and benefits, and advocate for your preferences.
|
|
|
|
|
|
Instagram @IMFmyeloma